Thabor Therapeutics
Paris-based company developing an innovative treatment for patients living with chronic mucosal inflammatory diseases
Thabor Therapeutics has raised €2.0M across 1 funding round from 1 investor, most recently a round in Jul 2022. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.thabor-tx.com ↗
Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-07
latest 2022-07
Funding by year
EUR raised per yearThabor Therapeutics — funding by year — interactive chart.
Data table
| Thabor Therapeutics — funding by year | |
|---|---|
| 2022 | €2.0M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-06 | Other | €2.0M | Bpifrance | View deal → |
Investors
1Related news
- Thabor Therapeutics brings in €2 million from Bpifrancetech.eu · 2022-07
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData